Mitochondria Activity and CXCR4 Collaboratively Promote the Differentiation of CD11c+ B Cells Induced by TLR9 in Lupus

키워드

참고문헌 (46)

1. Karrar S, "Abnormal B cell development in systemic lupus erythematosus : what the genetics tell us", Arthritis Rheumatol, 70, pp.496~507 (2018)
2. Caielli S, "Systemic lupus erythematosus pathogenesis : interferon and beyond", Annu Rev Immunol, 41, pp.533~560 (2023)
3. Jin W, "Peripheral B cell subsets in autoimmune diseases : clinical implications and effects of B cell-targeted therapies", J Immunol Res, 2020, pp.9518137~ (2020)
4. Rincon-Arevalo H, "Deep phenotyping of CD11c+ B cells in systemic autoimmunity and controls", Front Immunol, 12, pp.635615~ (2021)
5. Golinski ML, "CD11c+ B cells are mainly memory cells, precursors of antibody secreting cells in healthy donors", Front Immunol, 11, pp.32~ (2020)
6. Frasca D, "Hyper-metabolic B cells in the spleens of old mice make antibodies with autoimmune specificities", Immun Ageing, 18, pp.9~ (2021)
7. Song W, "Development of Tbet-and CD11c-expressing B cells in a viral infection requires T follicular helper cells outside of germinal centers", Immunity, 55, pp.290~307 (2022)
8. Cancro MP, "Cells", Annu Rev Immunol, 38, pp.315~340 (2020)
9. Meffre E, "Impaired B-cell tolerance checkpoints promote the development of autoimmune diseases and pathogenic autoantibodies", Immunol Rev, 292, pp.90~101 (2019)
10. Wang S, "IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE", Nat Commun, 9, pp.1758~ (2018)
11. Naradikian MS, "Cutting edge : IL-4, IL-21, and IFN-γ interact to govern T-bet and CD11c expression in TLR-activated B cells", J Immunol, 197, pp.1023~1028 (2016)
12. Horisberger A, "Measurement of circulating CD21-CD27-B lymphocytes in SLE patients is associated with disease activity independently of conventional serological biomarkers", Sci Rep, 12, pp.9189~ (2022)
13. Price MJ, "Progressive upregulation of oxidative metabolism facilitates plasmablast differentiation to a T-independent antigen", Cell Reports, 23, pp.3152~3159 (2018)
14. Wehrli N, "Changing responsiveness to chemokines allows medullary plasmablasts to leave lymph nodes", Eur J Immunol, 31, pp.609~616 (2001)
15. Muehlinghaus G, "Differential regulation of the expression of chemokine receptor 3 and 4 during plasma cell differentiation", Arthritis Res, 6(Suppl 1), pp.11~ (2004)
16. Lartigue A, "Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced murine lupus", J Immunol, 177, pp.1349~1354 (2006)
17. Ma K, "Roles of B cell-intrinsic TLR signals in systemic lupus erythematosus", Int J Mol Sci, 16, pp.13084~13105 (2015)
18. Klonowska-Szymczyk A, "Expression of toll-like receptors 3, 7, and 9 in peripheral blood mononuclear cells from patients with systemic lupus erythematosus", Mediators Inflamm, 2014, pp.381418~ (2014)
19. Papadimitraki ED, "Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus : implications for the induction and maintenance of the autoimmune process", Arthritis Rheum, 54, pp.3601~3611 (2006)
20. Shim JS, "The oxidative phosphorylation inhibitor IM156 suppresses B-cell activation by regulating mitochondrial membrane potential and contributes to the mitigation of systemic lupus erythematosus", Kidney Int, 103, pp.343~356 (2023)
21. Tan EM, "The 1982 revised criteria for the classification of systemic lupus erythematosus", Arthritis Rheum, 25, pp.1271~1277 (1982)
22. Bombardier C, "Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis Studies in SLE", Arthritis Rheum, 35, pp.630~640 (1992)
23. Krogmann AO, "Proinflammatory stimulation of toll-like receptor 9 with high dose CpG ODN 1826 impairs endothelial regeneration and promotes atherosclerosis in mice", PLoS One, 11, pp.e0146326~ (2016)
24. Behrens EM, "Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice", J Clin Invest, 121, pp.2264~2277 (2011)
25. Du SW, "Functional characterization of CD11c+ age-associated B cells as memory B cells", J Immunol, 203, pp.2817~2826 (2019)
26. Nickerson KM, "Age-associated B cells are heterogeneous and dynamic drivers of autoimmunity in mice", J Exp Med, 220, pp.e20221346~ (2023)
27. Li ZY, "Age", autoimmunity-associated B cells in inflammatory arthritis : an emerging therapeutic target, 2023, pp.14, 1103307~
28. Ma K, "Multiple functions of B cells in the pathogenesis of systemic lupus erythematosus", Int J Mol Sci, 20, pp.6021~ (2019)
29. Sachinidis A, "Age-associated B cells(ABCs)in the prognosis, diagnosis and therapy of systemic lupus erythematosus(SLE)", Mediterr J Rheumatol, 31, pp.311~318 (2020)
30. Rubtsova K, "B cells expressing the transcription factor T-bet drive lupus-like autoimmunity", J Clin Invest, 127, pp.1392~1404 (2017)
31. Liu Y, "T-bet+CD11c+ B cells are critical for antichromatin immunoglobulin G production in the development of lupus", Arthritis Res Ther, 19, pp.225~ (2017)
32. Christensen SR, "Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus", Immunity, 25, pp.417~428 (2006)
33. Fillatreau S, "Toll-like receptor signalling in B cells during systemic lupus erythematosus", Nat Rev Rheumatol, 17, pp.98~108 (2021)
34. Giorgiutti S, "CXCR4 : from B-cell development to B cell-mediated diseases", Life Sci Alliance, 7, pp.e202302465~ (2024)
35. Alouche N, "Hematologic disorder-associated Cxcr4 gain-of-function mutation leads to uncontrolled extrafollicular immune response", Blood, 137, pp.3050~3063 (2021)
36. Hamilton JA, "Autoreactive B cells in SLE, villains or innocent bystanders?", Immunol Rev, 292, pp.120~138 (2019)
37. Broketa M, "Single-cell technologies for the study of antibody-secreting cells", Front Immunol, 12, pp.821729~ (2022)
38. Elsner RA, "Germinal center and extrafollicular B cell responses in vaccination, immunity, and autoimmunity", Immunity, 53, pp.1136~1150 (2020)
39. Willette RN, "Modulation of oxidative phosphorylation with IM156 attenuates mitochondrial metabolic reprogramming and inhibits pulmonary fibrosis", J Pharmacol Exp Ther, 379, pp.290~300 (2021)
40. Bridges HR, "Structural basis of mammalian respiratory complex I inhibition by medicinal biguanides", Science, 379, pp.351~357 (2023)
41. Izreig S, "Repression of LKB1 by miR-17~92 sensitizes MYC-dependent lymphoma to biguanide treatment", Cell Rep Med, 1, pp.100014~ (2020)
42. Biajoux V, "Efficient plasma cell differentiation and trafficking require Cxcr4 desensitization", Cell Reports, 17, pp.193~205 (2016)
43. Cheng Q, "CXCR4-CXCL12 interaction is important for plasma cell homing and survival in NZB", W mice, 2018, pp.48, 1020~1029
44. Rubtsov AV, "Toll-like receptor 7(TLR7)-driven accumulation of a novel CD11c+ B-cell population is important for the development of autoimmunity", Blood, 118, pp.1305~1315 (2011)
45. Oh S, "Engineering cell therapies for autoimmune diseases : from preclinical to clinical proof of concept", Immune Netw, 22, pp.e37~ (2022)
46. Jung SM, "Targeted immunotherapy for autoimmune disease", Immune Netw, 22, pp.e9~ (2022)

관련 논문AI추천